Aggricease Injection 100ml

Aggricease Injection 100ml contains Tirofiban, a glycoprotein IIb/IIIa receptor antagonist indicated to prevent blood clots in patients with acute coronary syndromes (ACS), including unstable angina and non-ST-elevation myocardial infarction (NSTEMI). It functions by inhibiting platelet aggregation, thereby maintaining smooth blood flow in the arteries and reducing the risk of myocardial infarction and other cardiovascular complications. Aggricease Injection 100ml is administered under strict medical supervision in hospital or specialised care settings. Before administration, inform your doctor of any history of bleeding disorders, thrombocytopenia, renal disease, or recent surgical procedures. Aggricease Injection 100ml pricing varies by retailer and location.

Aggricease Injection uses are: Preventing blood clots in patients with unstable angina Reducing the risk of non-ST-elevation myocardial infarction (NSTEMI) Supporting percutaneous coronary intervention (PCI) to prevent platelet aggregation Managing acute coronary syndromes in high-risk patients

Tirofiban works by blocking the glycoprotein IIb/IIIa receptors on platelets, which prevents them from sticking together and forming clots. By inhibiting platelet aggregation, Aggricease Injection 100ml reduces the risk of artery blockage, ensuring proper blood flow to the heart and lowering the chances of heart attack or related complications.

Common Aggricease Injection side effects: Bleeding at injection site Nosebleeds Headache Dizziness Serious or rare side effects: Severe internal bleeding Low platelet count (thrombocytopenia) Allergic reactions Hypotension Seek immediate medical attention if you experience excessive bleeding, severe dizziness, or signs of an allergic reaction.